Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.82B P/E - EPS this Y 26.10% Ern Qtrly Grth -
Income -255.1M Forward P/E -66.70 EPS next Y 41.60% 50D Avg Chg 3.00%
Sales 618.73M PEG -0.44 EPS past 5Y - 200D Avg Chg 26.00%
Dividend N/A Price/Book 8.50 EPS next 5Y 51.40% 52W High Chg -8.00%
Recommedations 2.00 Quick Ratio 3.96 Shares Outstanding 105.11M 52W Low Chg 147.00%
Insider Own 2.47% ROA -12.22% Shares Float 102.65M Beta 1.92
Inst Own 92.51% ROE -32.98% Shares Shorted/Prior 8.58M/6.42M Price 58.70
Gross Margin 66.15% Profit Margin -41.23% Avg. Volume 943,083 Target Price 57.79
Oper. Margin -15.76% Earnings Date May 1 Volume 1,672,968 Change -5.70%
About 10x Genomics, Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

10x Genomics, Inc. News
03/26/24 10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
03/21/24 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
03/13/24 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
03/13/24 11 Oversold Healthcare Stocks To Buy Right Now
03/01/24 Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
02/27/24 Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
02/20/24 10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
02/16/24 10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript
02/16/24 Q4 2023 10X Genomics Inc Earnings Call
02/15/24 Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings
02/15/24 10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
02/15/24 10x Genomics Inc (TXG) Reports Solid Revenue Growth Amid Rising Operating Expenses in FY 2023
02/15/24 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
02/08/24 10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
02/07/24 10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
02/05/24 10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
02/05/24 Nanostring files for bankruptcy protection, explores possible sale
01/27/24 Companies Like 10x Genomics (NASDAQ:TXG) Are In A Position To Invest In Growth
01/24/24 10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
01/08/24 10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
TXG Chatroom

User Image Etrading Posted - 42 minutes ago

$TXG Added here with $tmdx and $sofi ... still waiting $spy put to pay but rigged market holding well

User Image Saguaroman Posted - 1 day ago

$TGTX just opened a position in $TXG yesterday. Anyone else ever been in this stock? Lots of potential, at the bottom of its channel and Cathie Wood’s ARK funds have been buying in. Would love to hear anyone’s bullish/bearish thesis

User Image Saguaroman Posted - 1 day ago

$TXG Cathy Wood’s $ARKK & $ARKG have been consistent buyers since early February with tons of purchases, including multiple in the past 10 days. Love to see it

User Image Stock_Titan Posted - 2 days ago

$TXG 10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay https://www.stocktitan.net/news/TXG/10x-genomics-commercially-launches-visium-hd-spatial-gene-expression-pl5lgcmb41n8.html

User Image Saguaroman Posted - 2 days ago

$TXG just started a new position this afternoon. Let’s make a run for the top of the channel 💪🏻

User Image Tejj Posted - 3 days ago

$TXG here is it. starter starts now

User Image Etrading Posted - 6 days ago

$SPY $txg this $35s and low $36s add for swing

User Image DonCorleone77 Posted - 6 days ago

$TXG Cathie Wood's ARK Investment bought 241K shares of 10x Genomics today

User Image Stock_Titan Posted - 6 days ago

$TXG 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel https://www.stocktitan.net/news/TXG/10x-genomics-expands-xenium-menu-with-multi-modal-cell-segmentation-rx640n0rt2e2.html

User Image TickerDD_com Posted - 1 week ago

From 3/11/2024, looking back across 22 Month-Ends for TXG, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $TXG #TXG #TXGStock #TickerDD https://www.youtube.com/watch?v=XpKr0IOpRRQ

User Image 2outted Posted - 1 week ago

$TXG

User Image tradingtwenty Posted - 1 week ago

Top 5 oversold stocks that have trended in the past 24 hours: $MEI 15.12 🔥 $FWRD 17.31 $TXG 24.27 $MMI 25.13 $BCE 25.35 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image Yaloo159 Posted - 1 week ago

Bullish Alert for $TXG 10X GENOMICS INC Swing: 14.30%

User Image ScamBuster0 Posted - 1 week ago

$TXG Anyone want to read complete corporate double-speak and BS? Here's what a rent-seeking scam company writes. No wonder it is now defending antitrust charges of patent misuse. NString should have led with this, not reacted with it. https://pages.10xgenomics.com/PATENT-PROTECTION.html And yes the Harvard patents are complete trash because they violate 35USC112 because in order to obtain a patent monopoly, one has to teach and enable a full scope of a claim. One cannot simple use vague terms to say "everything one might do later is ours." There is no boundary to this property right. And no this patent scam was not a 10X "invention", it was Harvard collecting rent to play its games.

User Image ScamBuster0 Posted - 1 week ago

$TXG Has anyone read the "PR" email this company sent out entitled "NanoString is promoting a false narrative to deflect blame?" OMG it's a PR case study in distorting and deflecting "public good" blame to cover up extreme greed and patent claim abuse. It's simple, TXG was using 1990's over-broad, functional patent claims from Church/Harvard to try to dominate downstream research of others. This is the same abusive technique Affymetrix used to try to dominate the "new" (~25 years ago) DNA microarray world when the actual invention was how Affy made their device (photolithography) but Affy claimed the result achieved regardless of the means used to achieve the result. Harvard did the same thing with the Church methods. Those Harvard patents should have easily been destroyed via PTAB and Euro opposition proceedings, the same way the Affy patents were destroyed many years ago. Also the way Merck destroyed the over-broad Honjo PD-1 patents. Funny how TXG failed to mention over-broad claims

User Image Stock_Titan Posted - 2 weeks ago

$TXG 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products https://www.stocktitan.net/news/TXG/10x-genomics-begins-commercial-shipments-of-chromium-gem-x-vzdgrt43ij4z.html

User Image Tejj Posted - 2 weeks ago

$TXG a couple bucks lower please

User Image JasonLg Posted - 2 weeks ago

$TXG Bottom of the channel - ready to reclaim $50 - $53

User Image Moreketchup Posted - 2 weeks ago

@symptl $TXG better watch out 🤣🤣

User Image MrHoser Posted - 2 weeks ago

@TheBullishOne007 @ParabolicPapa @LookinForGains I just bought $NSTGQ shares too because screw $TXG. Clearly they are not out to better people and customers. It's all about money and control.

User Image vesuvium Posted - 2 weeks ago

@Taurusthebullman Just ended about 10 minutes ago. ^^ This post is the most significant thing that happened on the meeting. The 2nd most significant thing was the overall attitude counsels for Harvard and $TXG had regarding their interest in the patent infringement liabilities and ensuring that NSTG's obligations to them as creditors be fulfilled in as timely a manner as possible.

User Image MrHoser Posted - 2 weeks ago

@ParabolicPapa I was just thinking of that! This $TXG move to grill $NSTGQ on the bankrupcy debtor call (of all places) was a scare tactic and just showed how scared 10x is that the litigation will be declared invalid. And to have Harvard College on the call to ask similar questions was the cherry on top. Congrats 10x...you shot yourselves in the foot.

User Image MrHoser Posted - 2 weeks ago

@shome1 @LookinForGains I've lost respect for $TXG. They are clearly not about progressing for health. It's all about cornering the market and control. Shame on you $TXG and Harvard College.

User Image MrHoser Posted - 2 weeks ago

$TXG rep asking for number of sales for each product and income. Trying to get $NSTGQ to lay ownership of litigation on new buyers.

User Image MrHoser Posted - 2 weeks ago

$NSTGQ Holy hell. $TXG and Harvard College on the debitor call trying to sabatoge the bankrupcy debitor hearring.

User Image MrCoppersmith Posted - 2 weeks ago

$TXG This kind of reminds me of $DMTK fate and where it is currently!

User Image MrCoppersmith Posted - 2 weeks ago

$TXG the motley fool recommended buy this at 180, and sold it around 40! They claimed this will 10x 😂 Isn’t that amazing, while sp500 up 30% their 10x portfolio is down 22% However, they still have another 12 yrs to go out of 15 yrs time frame!! Not sure how ppl continue to buy their services!

User Image Tangidong Posted - 2 weeks ago

$TXG why down so much?

User Image MrHoser Posted - 02/29/24

$NSTGQ $TXG If the patent US ruling is overturned just as UPC has...could NanoString counter sue for all the loss and damage caused by TXG?

User Image Yourmatefromdownunder Posted - 1 month ago

$TXG This is going to take off soon, if you don’t have a position get one now!

Analyst Ratings
Stifel Buy Feb 16, 24
Barclays Overweight Jan 25, 24
Guggenheim Buy Dec 14, 23
Wolfe Research Outperform Dec 13, 23
B of A Securities Neutral Dec 12, 23
Barclays Overweight Sep 29, 23
Canaccord Genuity Buy Sep 19, 23
Morgan Stanley Overweight Aug 7, 23
Barclays Overweight Aug 4, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Dec 14 Sell 54.77 2,000 109,540 845,446 12/18/23
Wilbur James Chief Commercial Off.. Chief Commercial Officer Nov 22 Sell 43.3367 3,464 150,118 83,342 11/27/23
Hindson Benjamin J. See Remarks See Remarks Nov 22 Sell 43.3367 3,449 149,468 277,338 11/27/23
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer Nov 22 Sell 43.3367 1,679 72,762 97,105 11/27/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Nov 22 Sell 43.53 7,480 325,604 847,446 11/27/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Sep 14 Sell 49.59 2,000 99,180 862,093 09/18/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Aug 22 Sell 45.7811 3,757 172,000 864,093 08/24/23
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer Aug 22 Sell 45.7811 1,678 76,821 98,784 08/24/23
Wilbur James Chief Commercial Off.. Chief Commercial Officer Aug 22 Sell 45.7811 9,699 444,031 101,253 08/24/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Aug 14 Sell 50.26 2,000 100,520 867,850 08/16/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Jul 19 Sell 60.03 40,000 2,401,200 869,850 07/21/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Jul 19 Option 5.04 20,845 105,059 909,850 07/21/23
Hindson Benjamin J. See Remarks See Remarks Jul 19 Sell 60.03 13,940 836,818 284,236 07/21/23
Hindson Benjamin J. See Remarks See Remarks Jul 19 Option 8.26 13,940 115,144 298,176 07/21/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Jul 14 Sell 57.99 2,000 115,980 889,005 07/18/23
STUELPNAGEL JOHN R Director Director Jun 05 Sell 54.8894 10,000 548,894 333,736 06/07/23
Hindson Benjamin J. See Remarks See Remarks May 23 Sell 55.06 2,388 131,483 284,236 05/25/23
Wilbur James Chief Commercial Off.. Chief Commercial Officer May 23 Sell 55.0653 316 17,401 110,952 05/25/23
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer May 23 Sell 55.06 1,665 91,675 100,462 05/25/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer May 19 Sell 55.06 2,602 143,266 893,190 05/23/23
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer Feb 22 Sell 47.7533 1,245 59,453 75,519 02/24/23
Hindson Benjamin J. See Remarks See Remarks Feb 22 Sell 47.7533 1,742 83,186 250,237 02/24/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Feb 22 Sell 47.7533 1,941 92,689 909,715 02/24/23
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Nov 22 Sell 34.07 2,676 91,171 974,926 11/23/22
Hindson Benjamin J. See Remarks See Remarks Nov 22 Sell 34.07 2,361 80,439 217,713 11/23/22
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer Nov 22 Sell 34.07 1,626 55,398 76,764 11/23/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Sep 12 Option 1.2 11,500 13,800 977,602 09/14/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Aug 23 Sell 35.1913 2,715 95,544 966,102 08/25/22
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer Aug 23 Sell 35.1913 987 34,734 58,092 08/25/22
Hindson Benjamin J. See Remarks See Remarks Aug 23 Sell 35.1913 1,292 45,467 186,246 08/25/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer May 23 Sell 48.7636 2,656 129,516 968,817 05/25/22
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer May 23 Sell 48.7641 967 47,155 59,079 05/25/22
Hindson Benjamin J. See Remarks See Remarks May 23 Sell 48.7636 1,264 61,637 187,538 05/25/22
CRUTCHFIELD BRADFORD Chief Commercial Off.. Chief Commercial Officer May 23 Sell 48.7642 286 13,947 97,237 05/25/22
Kosaraju Sridhar Director Director May 16 Option 11.48 15,000 172,200 18,458 05/17/22
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer May 13 Buy 40.4855 158 6,397 60,046 05/17/22
CRUTCHFIELD BRADFORD Chief Commercial Off.. Chief Commercial Officer May 13 Buy 40.4855 158 6,397 97,523 05/17/22
Hindson Benjamin J. See Remarks See Remarks Feb 22 Sell 78.5944 360 28,294 160,326 02/24/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Feb 22 Sell 78.6003 551 43,309 912,742 02/24/22
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer Feb 22 Sell 78.5994 288 22,637 38,531 02/24/22
CRUTCHFIELD BRADFORD Chief Commercial Off.. Chief Commercial Officer Feb 22 Sell 78.5993 288 22,637 97,365 02/24/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Feb 08 Option 11.48 3,038 34,876 925,293 02/10/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Feb 08 Sell 89.67 12,000 1,076,040 913,293 02/10/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Jan 04 Option 11.48 3,037 34,865 937,255 01/06/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Jan 04 Sell 142.08 15,000 2,131,200 922,255 01/06/22
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Dec 28 Option 1.2 56,363 67,636 934,218 12/30/21
Hindson Benjamin J. See Remarks See Remarks Dec 28 Option 1.14 113,920 129,869 160,686 12/30/21
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Dec 07 Option 8.26 8,246 68,112 892,855 12/09/21
Saxonov Serge Chief Executive Offi.. Chief Executive Officer Dec 07 Sell 144.79 15,000 2,171,850 877,855 12/09/21
McAnear Justin J. Chief Financial Offi.. Chief Financial Officer Dec 01 Option 5.04 10,000 50,400 48,819 12/03/21